News & Insights

cancer treatment nanoparticles

Science Fiction is now True in 2022

Global Cancer Technology is innovating the treatment of deadly diseases like glioblastoma – it’s not science fiction any more! Scintillating nanoparticles can theoretically be coated in GCT’s cancer inhibitor that is currently being tested in animal models, then be injected into the bloodstream and designed to bind to the tumor’s surface.

innovative cancer treatments for patients

The Future of Cancer Treatment Looks Bright

Over the last few months, more than $30 billion has been invested in biotechnology companies to spur research and development, particularly in the area of cancer treatments. Companies like Global Cancer Technology are developing innovative treatments in an effort to one day halt the progression of deadly diseases like glioblastoma.

cancer treatment biotech GCT

Why are Cancer Patients Skipping Their Treatments?

Cancer patients have been skipping their treatments since the pandemic began. In some cases, clinics have temporarily closed their facilities or halted their procedures due to the outbreak; in other cases, patients have been afraid of contracting the virus.


Imagion to develop nanocrystals for treating breast cancer

Early cancer detection specialist Imagion Biosystems Limited (ASX: IBX) has entered into a Joint…


Biotech Daily (newsletter) – Imagion, GCT work on nano-scintillator for breast cancer

Thursday August 12, 2021 Daily news on ASX-listed biotechnology companies * AS X FLAT, BIOTECH…


Imagion Biosystems (ASX:IBX) up on deal to develop breast cancer treatment

Shares of Imagion Biosystems (ASX:IBX) jumped as much as 9% to AU$0.085, their highest since…


Imagion Biosystems Enters Agreement to Develop Nanocrystals for Treating Breast Cancer

Imagion Biosystems is pleased to announce it has entered into a Joint Development Agreement…


Phoenix and Maricopa County Proclaim July 21st as Glioblastoma Awareness Day

PHOENIX, July 21, 2021 /PRNewswire/ — In recognition of the local strides being made in the…


San Diego company aiming to target glioblastoma with nanotechnology-based approach

The emerging biopharmaceutical company Global Cancer Technology (GCT; San Diego) is…


Global Cancer Technology Appoints Chief Scientific Consultant and Advisor

GCT strengthens science development team with top appointment of biotech and…


BioSpace Movers & Shakers

Biopharma and life sciences organizations strengthen their leadership teams and board with…


What Will It Take to Bring Glioblastoma Research to the Forefront?

Dr. Loralyn Mears is the Director of Scientific Communications for Global Cancer Technology, and..